Literature DB >> 19466506

Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome.

Ko Sasaki1, Toshiyuki Tahara2, Kinuko Mitani3.   

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited disease characterized by recurrent episodes of systemic inflammation. The cause of this disease is the mutations affecting both the alleles of MEFV gene. We describe here a case in a heterozygous MEFV mutation complicated with myelodysplastic syndrome (MDS). Clinical symptoms and the effectiveness of colchicines in this patient are typical for FMF. The first attack of FMF in this patient was observed during immunosuppressive therapy for MDS. This case suggests the possibility that certain immunosuppressants may trigger FMF attack in asymptomatic cases carrying MEFV heterozygous mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466506     DOI: 10.1007/s12185-009-0336-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

1.  Familial Mediterranean fever triggered by renal transplantation.

Authors:  Hamid Tayebi Khosroshahi; R Shane Tubbs; Mohammadali Mohajel Shoja
Journal:  Nephrol Dial Transplant       Date:  2006-05-30       Impact factor: 5.992

2.  The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.

Authors:  M Centola; G Wood; D M Frucht; J Galon; M Aringer; C Farrell; D W Kingma; M E Horwitz; E Mansfield; S M Holland; J J O'Shea; H F Rosenberg; H L Malech; D L Kastner
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

Review 3.  The spectrum of Familial Mediterranean Fever (FMF) mutations.

Authors:  I Touitou
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

4.  A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD).

Authors:  A Livneh; I Aksentijevich; P Langevitz; Y Torosyan; N G-Shoham; Y Shinar; E Pras; N Zaks; S Padeh; D L Kastner; M Pras
Journal:  Eur J Hum Genet       Date:  2001-03       Impact factor: 4.246

5.  Clinical differences between North African and Iraqi Jews with familial Mediterranean fever.

Authors:  E Pras; A Livneh; J E Balow; E Pras; D L Kastner; M Pras; P Langevitz
Journal:  Am J Med Genet       Date:  1998-01-13

6.  A candidate gene for familial Mediterranean fever.

Authors: 
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

9.  Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter.

Authors:  A E Goldfeld; P G McCaffrey; J L Strominger; A Rao
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

  9 in total
  2 in total

1.  High frequency of MEFV gene mutations in patients with myeloid neoplasm.

Authors:  Cagatay Oktenli; Ozkan Sayan; Serkan Celik; Alev A Erikci; Yusuf Tunca; Hakan M Terekeci; Elcin Erkuvan Umur; Yavuz S Sanisoglu; Deniz Torun; Fatih Tangi; Burak Sahan; Selim Nalbant
Journal:  Int J Hematol       Date:  2010-05-01       Impact factor: 2.490

Review 2.  High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

Authors:  Cagatay Oktenli; Serkan Celik
Journal:  Int J Hematol       Date:  2012-03-28       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.